scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VETIMM.2016.04.001 |
P698 | PubMed publication ID | 27090627 |
P2093 | author name string | Amanda A Adams | |
Kellie E McMurry | |||
Melissa H Siard | |||
P2860 | cites work | Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats | Q24597042 |
Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation | Q28171193 | ||
Molecular targets of dietary polyphenols with anti-inflammatory properties | Q28192995 | ||
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination | Q33465128 | ||
Inflammatory networks during cellular senescence: causes and consequences | Q33889156 | ||
Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway | Q34415256 | ||
Potent anti-cancer effect of 3'-hydroxypterostilbene in human colon xenograft tumors | Q34497336 | ||
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis | Q34586580 | ||
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study | Q35448046 | ||
Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. | Q35535358 | ||
Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations | Q35821696 | ||
Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
Medical treatment of osteoarthritis in the horse - a review | Q36374283 | ||
Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
Regulation of SIRT1 in cellular functions: role of polyphenols | Q37745178 | ||
Conundrum and Therapeutic Potential of Curcumin in Drug Delivery | Q37798847 | ||
Nutritional aspects of metabolic inflammation in relation to health--insights from transcriptomic biomarkers in PBMC of fatty acids and polyphenols | Q38180657 | ||
Curcumin: a pleiotropic phytonutrient in diabetic complications | Q38274113 | ||
Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development | Q38708186 | ||
Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol | Q38918022 | ||
The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages | Q39220608 | ||
Phenylbutazone in the horse: a review | Q39732258 | ||
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo | Q39804379 | ||
Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. | Q40668576 | ||
Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s). | Q40728869 | ||
Resveratrol modulates interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear factor κB signaling pathways in human tenocytes | Q41521612 | ||
Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway | Q41786171 | ||
Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? | Q42333984 | ||
Curcumin attenuates the effects of transport stress on serum cortisol concentration, hippocampal NO production, and BDNF expression in the pig | Q42870317 | ||
Seasonal variation in serum concentrations of selected metabolic hormones in horses | Q43102792 | ||
NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy | Q43138461 | ||
A cross-sectional study of geriatric horses in the United Kingdom. Part 1: Demographics and management practices. | Q43691386 | ||
Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). | Q43989423 | ||
Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses | Q44691439 | ||
In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway | Q45237108 | ||
Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice | Q45243008 | ||
Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism | Q45285305 | ||
Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. | Q46010001 | ||
Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses | Q46267468 | ||
The effect of age and telomere length on immune function in the horse | Q46489025 | ||
COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis | Q46531185 | ||
Pharmacokinetics and tissue distribution of pterostilbene in the rat. | Q46863513 | ||
Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses | Q46967895 | ||
Effect of body condition, body weight and adiposity on inflammatory cytokine responses in old horses | Q47202607 | ||
Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study | Q48037884 | ||
Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart | Q50221073 | ||
The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats. | Q51484569 | ||
One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease | Q57759758 | ||
Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant | Q72243672 | ||
Bioavailability and metabolism of the flavonol quercetin in the pig | Q73835611 | ||
NORMAL BLOOD VOLUMES IN THE HORSE | Q76915039 | ||
Advanced age in horses affects divisional history of T cells and inflammatory cytokine production | Q79623301 | ||
Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs | Q79852448 | ||
Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme | Q81225505 | ||
Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses | Q82499272 | ||
Foals are interferon gamma-deficient at birth | Q83168358 | ||
Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa | Q85692028 | ||
P921 | main subject | polyphenol | Q290439 |
lymphocyte | Q715347 | ||
P304 | page(s) | 50-59 | |
P577 | publication date | 2016-04-04 | |
P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
P1476 | title | Effects of polyphenols including curcuminoids, resveratrol, quercetin, pterostilbene, and hydroxypterostilbene on lymphocyte pro-inflammatory cytokine production of senior horses in vitro | |
P478 | volume | 173 |
Search more.